COVID 19 infection clinical features in pediatric patients in Southwestern Iran: a cross-sectional, multi-center

Marzieh Jamalidoust1, Mohsen Jalil2, Zahra Ashkan3

  • 1Clinical Microbiology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

BMC Infectious Diseases
|November 25, 2023
PubMed

Insights

This study found that 13.51% of children suspected of having COVID-19 in Iran tested positive. Children with underlying conditions like malignancy and diabetes had higher infection rates.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Epidemiology

Background:

  • The SARS-CoV-2 pandemic has had a significant impact on global health, including pediatric populations.
  • Understanding the epidemiology of COVID-19 in children is crucial for public health strategies.

Purpose of the Study:

  • To evaluate SARS-CoV-2 infection rates and associated clinical features in children under 18.
  • To identify risk factors and demographic characteristics of pediatric COVID-19 cases in specific Iranian provinces.

Main Methods:

  • A retrospective study involving 5943 children suspected of SARS-CoV-2 infection.
  • Data collection included demographic, clinical, and underlying condition information from February 2020 to June 2021.
  • Real-time PCR was used for confirmation of SARS-CoV-2 infection.

Main Results:

  • 13.51% of suspected pediatric cases tested positive for SARS-CoV-2.
  • The mean age of infected children was 5.71 years, with a female/male ratio of 1:1.3.
  • Children with malignancy (highest rate) and diabetes showed significantly higher COVID-19 rates compared to other underlying conditions.
  • 11.2% of confirmed pediatric cases required Pediatric Intensive Care Unit (PICU) admission.
  • The 10-18 year age group had the most COVID-19 cases, with no significant sex-based difference in susceptibility.

Conclusions:

  • Children of all ages are susceptible to SARS-CoV-2 infection.
  • Pre-existing conditions, particularly malignancy and diabetes, are associated with increased risk of COVID-19 in children.
  • The findings highlight the importance of monitoring and protecting vulnerable pediatric populations during the pandemic.

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...